Cargando…
Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic
Autores principales: | Kang, Lois, Goldman, Maya, Uyehara, Anny, Goldman, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849591/ http://dx.doi.org/10.1016/j.jaci.2020.12.603 |
Ejemplares similares
-
Continuing Peanut Oral Immunotherapy via Telemedicine During the COVID-19 Pandemic
por: Schoonover, Anna, et al.
Publicado: (2021) -
Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules: Need for prospective data
por: Larenas-Linnemann, Désirée Erlinda, et al.
Publicado: (2020) -
Ultrarush schedule of subcutaneous immunotherapy with modified allergen extracts is safe in paediatric age
por: Morais-Almeida, Mário, et al.
Publicado: (2016) -
Comparative study of novel dosing schedules for interrupted immunotherapy for allergic rhinitis
por: Xi, Lin, et al.
Publicado: (2022) -
Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
por: Alsolaihim, Alanood, et al.
Publicado: (2020)